Published by Michele Maatouk on 8th January 2024
(Sharecast News) - Johnson & Johnson said on Monday that it has agreed to buy clinical-stage biopharmaceutical company Ambrx for around $2bn.
URL: http://www.digitallook.com/dl/news/story/34010508/...